Hexagon Capital Partners’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-163
| Closed | -$1.06K | – | 1667 |
|
|
2025
Q1 | $1.06K | Hold |
163
| – | – | ﹤0.01% | 1539 |
|
|
2024
Q4 | $1.2K | Buy |
163
+33
| +25% | +$242 | ﹤0.01% | 1529 |
|
|
2024
Q3 | $974 | Sell |
130
-1
| -0.8% | -$7 | ﹤0.01% | 1334 |
|
|
2024
Q2 | $1.17K | Sell |
131
-6
| -4% | -$53 | ﹤0.01% | 1245 |
|
|
2024
Q1 | $1.39K | Sell |
137
-39
| -22% | -$395 | ﹤0.01% | 1224 |
|
|
2023
Q4 | $1.77K | Sell |
176
-140
| -44% | -$1.41K | ﹤0.01% | 1152 |
|
|
2023
Q3 | $2.96K | Sell |
316
-442
| -58% | -$4.14K | ﹤0.01% | 999 |
|
|
2023
Q2 | $18.6K | Buy |
758
+82
| +12% | +$2.01K | ﹤0.01% | 581 |
|
|
2023
Q1 | $15.7K | Sell |
676
-143
| -17% | -$3.33K | ﹤0.01% | 617 |
|
|
2022
Q4 | $20.7K | Buy |
819
+356
| +77% | +$9.01K | 0.01% | 536 |
|
|
2022
Q3 | $9K | Buy |
463
+143
| +45% | +$2.78K | ﹤0.01% | 812 |
|
|
2022
Q2 | $8K | Buy |
+320
| New | +$8K | ﹤0.01% | 708 |
|
|
2022
Q1 | – | Sell |
-286
| Closed | -$12K | – | 988 |
|
|
2021
Q4 | $12K | Buy |
+286
| New | +$12K | ﹤0.01% | 584 |
|